Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
The role of transcription factor PAX2 in mediating glomerular repair in a mouse model of focal segmental glomerulosclerosis
FY 2022-23
Summary
Focal Segmental Glomerulosclerosis (FSGS) is a severe form of chronic kidney disease that injures the blood-filtering cells of the kidney and often leads to kidney failure. Development of treatments for FSGS has been stagnant for decades, and kidney failure is irreversible and can only be managed by dialysis and kidney transplant. For many years, it was widely accepted that the kidney has a very limited capability to regenerate after an injury such as in FSGS. However, recent studies have challenged this view and showed that kidney cells are quite capable of regeneration, but these studies lack details on specific cellular and molecular mechanisms. We previously found that mutations in a gene called PAX2 account for 4% of adults with FSGS. My research explores what role PAX2 plays in normal kidney repair and how PAX2 mutations lead to FSGS. My current findings show PAX2 mutant mice have a more severe FSGS disease compared to normal mice, including worsened kidney tissue damage and severely impaired kidney function. I propose that kidney cells expressing mutant PAX2 are compromised in their ability to repair after FSGS injury. To test this, I am performing techniques that can identify thousands of genes and proteins at a single-cell level to precisely map what molecules and signals are produced by PAX2-expressing cells in the kidney. I will also use these techniques to examine the molecular profile of PAX2-expressing cells from mutant and normal mice kidneys and compare their function and ability to regenerate cells injured from FSGS. Studies will also be performed in these mice where PAX2-expressing cells are tracked using genetic and fluorescent markers, to observe how they change throughout the course of FSGS injury and to determine whether they can regenerate the damaged kidney cells. In summary, my research explores the role of PAX2 in kidney repair mechanisms, with the broader goal of utilizing my findings towards the development of novel treatments for FSGS.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
475619
Name
Cunanan Joanna
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of transcription factor PAX2 in mediating glomerular repair in a mouse model of focal segmental glomerulosclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cell Lineage Fate Mapping; Chronic Kidney Disease; Focal Segmental Glomerulosclerosis; Pax2; Proteomics; Repair And Regeneration; Single-Cell Rna Sequencing; Super Resolution Microscopy
Abstract
Focal Segmental Glomerulosclerosis (FSGS) is a severe form of chronic kidney disease that injures the blood-filtering cells of the kidney and often leads to kidney failure. Development of treatments for FSGS has been stagnant for decades, and kidney failure is irreversible and can only be managed by dialysis and kidney transplant. For many years, it was widely accepted that the kidney has a very limited capability to regenerate after an injury such as in FSGS. However, recent studies have challenged this view and showed that kidney cells are quite capable of regeneration, but these studies lack details on specific cellular and molecular mechanisms. We previously found that mutations in a gene called PAX2 account for 4% of adults with FSGS. My research explores what role PAX2 plays in normal kidney repair and how PAX2 mutations lead to FSGS. My current findings show PAX2 mutant mice have a more severe FSGS disease compared to normal mice, including worsened kidney tissue damage and severely impaired kidney function. I propose that kidney cells expressing mutant PAX2 are compromised in their ability to repair after FSGS injury. To test this, I am performing techniques that can identify thousands of genes and proteins at a single-cell level to precisely map what molecules and signals are produced by PAX2-expressing cells in the kidney. I will also use these techniques to examine the molecular profile of PAX2-expressing cells from mutant and normal mice kidneys and compare their function and ability to regenerate cells injured from FSGS. Studies will also be performed in these mice where PAX2-expressing cells are tracked using genetic and fluorescent markers, to observe how they change throughout the course of FSGS injury and to determine whether they can regenerate the damaged kidney cells. In summary, my research explores the role of PAX2 in kidney repair mechanisms, with the broader goal of utilizing my findings towards the development of novel treatments for FSGS.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cunanan, Joanna
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~